Profile
BIMI ONC WBA DFTX HROWL HROWM
Company Name BIMI International Medical Inc. BeOne Medicines Ltd. Walgreens Boots Alliance, Inc. Definium Therapeutics, Inc. Harrow Health, Inc. 8.625% Senior Notes due 2026 Harrow Health, Inc. 11.875% Senior Notes due 2027
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Pharmaceuticals Medical - Pharmaceuticals Medical - Pharmaceuticals Medical - Pharmaceuticals Medical - Pharmaceuticals Medical - Pharmaceuticals
Market Cap $1.16K $37.82B $10.37B $1.64B $1.37B $1.34B
Employees 0.30K 11.00K 193.00K 0.07K 0.22K 0.22K
CEO Tiewei Song John V. Oyler Timothy C. Wentworth Robert Barrow Mark L. Baum Mark L. Baum
Ratings
BIMI ONC WBA DFTX HROWL HROWM
Quant Rating Score 2 2 2 1 1 1
Quant Rating Sell Sell Sell Strong Sell Strong Sell Strong Sell
Trading
BIMI ONC WBA DFTX HROWL HROWM
Last Close $0.0001 $376.63 $11.98 - $25.61 $26.03
High 52 $0.04 $377.81 $12.93 - $25.72 $26.95
Low 52 - $175.1 $8.24 - $25.01 $25.85
Price vs. 52 Week High -99.75 % -0.31 % -7.35 % - -0.43 % -3.41 %
Price vs. 52 Week Low 0 % 115.09 % 45.39 % - 2.4 % 0.7 %
Total Return
BIMI ONC WBA DFTX HROWL HROWM
1 Month Return 0 % 19.03 % 0 % - 0 % 0 %
3 Month Return 0 % 17.95 % -0.17 % - 0.55 % -1.33 %
6 Month Return -66.67 % 64.91 % 6.11 % - 1.23 % -0.78 %
9 Month Return -50 % 58 % 8.32 % - 1.13 % -2.87 %
YTD Return -90.91 % 104.69 % 28.4 % - 1.32 % -0.69 %
1 Year Return -98.67 % 0 % 44.51 % - 1.31 % -1.03 %
3 Year Return 0 % 0 % 0 % - 0 % 0 %
5 Year Return 0 % 0 % 0 % - 0 % 0 %
Dividends
BIMI ONC WBA DFTX HROWL HROWM
Dividend Yield Percentage (TTM) - - - - - -
Dividend Paid and Capex Coverage Ration (TTM) - 2.45 % 0.96 % - 0.46 % 0.46 %
Dividend Per Share (TTM) - - - - - -
Payout Ratio (TTM) - - -10.29 % - - -
Profitability
BIMI ONC WBA DFTX HROWL HROWM
Gross Profit Margin TTM 16.48 % 86.11 % 17.13 % - 74.56 % 74.56 %
Return on Assets TTM -62.7 % 1.06 % -9.07 % -70.95 % -1.37 % -1.37 %
Return on Equity TTM -293.85 % 2.19 % -70.17 % -86.18 % -8.96 % -8.96 %
Return on Capital Employed TTM -148.16 % 3.06 % -7.17 % -88.16 % 9.35 % 9.35 %
Net Income Per EBT TTM 103.57 % 39.97 % 107.6 % 100 % 90.66 % 90.66 %
EBT Per Ebit TTM 140.97 % 125.31 % 187.84 % 111.18 % -19.78 % -19.78 %
EBIT Per Revenue TTM -129.65 % 3.2 % -2.02 % - 11.13 % 11.13 %
Cash Flow To Debt Ratio TTM -187.98 % 77 % 5.43 % - 7.02 % 7.02 %
Receivables Turnover TTM 2.83 5.83 23.42 - 3.21 3.21
Payables Turnover TTM 0.92 1.82 9.41 - 3.35 3.35
Inventory Turnover TTM 1.29 1.31 17.5 - 4.96 4.96
Fixed Asset Turnover TTM 254.64 % 284.64 % 556.84 % - 2202.82 % 2202.82 %
Asset Turnover TTM 33.12 % 65.95 % 222.72 % - 68.87 % 68.87 %
Operating Cash Flow Per Share TTM -3.85 7.13 1.82 -1.33 0.48 0.48
Free Cash Flow Per Share TTM -3.85 4.22 0.67 -1.33 -0.55 -0.55
Cash Per Share TTM 87.68 % 3662.7 % 95.96 % 243.43 % 200 % 200 %
Operating Cash Flow Sales Ratio TTM -86.69 % 15.6 % 1.02 % - 7.07 % 7.07 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 59.15 % 36.78 % 100 % -115.84 % -115.84 %
Cash Flow Coverage Ratios TTM -187.98 % 77 % 5.43 % - 7.02 % 7.02 %
Price To Free Cash Flows Ratio TTM - 88.39 17.88 -14.42 -85.37 -85.6
Price To Operating Cash Flows Ratio TTM - 5.51 6.57 -12.74 99.18 99.45
Price Cash Flow Ratio TTM - 5.51 6.57 -12.74 99.18 99.45
Income Statement (TTM)
BIMI ONC WBA DFTX HROWL HROWM
Revenue $0.01B $3.81B $147.66B $0B $0.2B $0.2B
Gross Profit $0B $3.22B $26.52B $-0B $0.15B $0.15B
Gross Profit Ratio 16.48% 84.41% 17.96% 0% 75.33% 75.33%
EBITDA $-0.02B $-0.4B $-11.28B $-0.11B $0.02B $0.02B
Net Income $-0.02B $-0.64B $-8.64B $-0.11B $-0.02B $-0.02B
EPS Diluted -8.4 -6.12 -10.01 -0.15 -0.49 -0.49
Balance Sheet (MRQ)
BIMI ONC WBA DFTX HROWL HROWM
Long Term Debt $0B $0.21B $29.88B $0.02B $0.23B $0.23B
Total Liabilities $0.03B $2.59B $68.86B $0.06B $0.32B $0.32B
Total Equity $0.01B $3.33B $12.18B $0.24B $0.07B $0.07B
Total Investments $0B $0.13B $4.06B $0B $0B $0B
Total Debt $0.01B $1.08B $33.77B $0.02B $0.23B $0.23B
Total Assets $0.04B $5.92B $81.04B $0.3B $0.39B $0.39B
Cash Flow Statement (TTM)
BIMI ONC WBA DFTX HROWL HROWM
Net Income $-0.02B $-0.64B $-15.45B $-0.11B $-0.02B $-0.02B
Inventory $-0.01B $-0.09B $-0.03B $0B $0B $0B
Dividends Paid $0B $0B $-1.26B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.14B $1.02B $-0.08B $-0.02B $-0.02B
Capital Expenditure $0B $-0.53B $-1.38B $0B $-0.04B $-0.04B
Related Stocks
Ticker Name Price
AIXC Qualigen Therapeutics, Inc. 1.37
ATAI Atai Life Sciences N.V. 3.86
ATNFW CannBioRx Life Sciences Corp. 0.43
BGMS Bio Green Med Solution, Inc. 1.02
BGMSP Bio Green Med Solution, Inc. 3.73
CGEM Cullinan Oncology, Inc. 12.21
CJJD China Jo-Jo Drugstores, Inc. 1.52
DFTX Mind Medicine (MindMed) Inc. 17.375
HITI High Tide Inc. 2.37
HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares 0.8239
HROWL Harrow Health, Inc. 8.625% Senior Notes due 2026 25.61
HROWM Harrow Health, Inc. 11.875% Senior Notes due 2027 26.03
KYNB FibroGen, Inc. 7.78
LFLY Leafly Holdings, Inc. 37
LFLYW Leafly Holdings, Inc. 0.004
LFMD LifeMD, Inc. 3.045
LFMDP LifeMD, Inc. 22.4
MDVL MedAvail Holdings, Inc. 1.8
MEDS TRxADE HEALTH, Inc. 7.59
MSLE Satellos Bioscience Inc. Common Stock 11.06
Unlock